c.silva
TL2 · Kuopio
Contributes reviews on supplier material. Based in Kuopio.
Joined 5 December 2024 · last posted 4d
78 posts, newest first. Showing up to 150.
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #33 · Evidence › Preprints · 24 Jul 2026 · 0 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Submitting a sample: the process end to end Replied, post #104 · Sourcing › Independent verification · 23 Jul 2026 · 13 likes Picking up post #103: that is the part I would want checked first. The record shows what was measured. Everything beyond that is inference and this site tries to keep…
-
Common supplements people ask about, assessed one at a time Replied, post #68 · Practice › Interactions · 19 Jul 2026 · 0 likes The arithmetic in post #67 is right; the assumption feeding it is the part to check. Two claims get bundled together under common supplements and they need separating.…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #41 · Clinical › Prescriber conversations · 16 Jul 2026 · 3 likes Reading back through, this was answered upthread and I missed it. My fault.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #69 · Access › International · 10 Jul 2026 · 0 likes Where I part company with post #65, and it is a narrow parting. Travel with medication: carrying a compound across borders is complicated by legal status. Documenting…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #8 · Practice › Dosing & titration · 21 Jun 2026 · 0 likes Worth separating two things that post #6 runs together. Writing down the date, the dose and the site each week takes fifteen seconds and is the single most useful…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #76 · Practice › Administration · 18 Jun 2026 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #7 · Analytics › Home & field testing · 16 Jun 2026 · 29 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Semaglutide and alcohol: what is actually documented Replied, post #4 · Compounds › Semaglutide · 17 May 2026 · 28 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
Five questions in one post gets you one answer — how to split them Replied, post #81 · Start Here › How to Ask · 15 May 2026 · 0 likes Chromatography questions need the method before anything else: column, gradient, wavelength, injection volume. A purity figure with no method attached cannot be…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #27 · Analytics › Mass spectrometry · 14 May 2026 · 24 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Started this topic · Practice › Dosing & titration · 11 May 2026 · 0 likes Revisiting: The arithmetic of an intermediate dose between two label steps Writing it up because I had to work it out twice and would rather nobody else did. I have…
-
Citation sweep results: how many references did not say what was claimed Replied, post #89 · Meta › Wiki maintenance · 4 May 2026 · 10 likes Practical note on citation sweep results: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #95 · Practice › Interactions · 30 Apr 2026 · 0 likes Post #92 and I disagree about the size of the effect, not about the direction. What I can speak to on Metformin co-administration is narrow, so I will keep it narrow…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #34 · Practice › Reconstitution · 19 Apr 2026 · 9 likes Worth separating two things that post #32 runs together. Swirling until fully clear before drawing is worth the extra minute. A partially dissolved preparation is not…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #7 · Research Methods › N-of-1 designs · 16 Apr 2026 · 0 likes Post #5 is the version of this I will quote in future. One addition. Order effects matter. If you always try A before B, you cannot separate the treatment from the…
-
The "under review" status pill and when a moderator applies it Replied, post #63 · Evidence › Preprints · 9 Apr 2026 · 16 likes The arithmetic in post #62 is right; the assumption feeding it is the part to check. Peer review catches some things reliably — missing methods, unsupported…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #58 · Analytics › Mass spectrometry · 6 Apr 2026 · 1 like Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
Research-use-only status: what it means legally and practically Replied, post #21 · Compounds › Other compounds · 31 Mar 2026 · 2 likes Answering the question post #17 raises rather than the one it answers. My experience of research-use-only status contradicts the reply above. I am posting it as a data…
-
The lowest dose that does anything: is that a real question? Replied, post #94 · Practice › Dosing & titration · 7 Mar 2026 · 0 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Contributing data without breaching anyone's privacy Replied, post #42 · Data & Tools › Datasets · 5 Mar 2026 · 1 like Where a dataset is used to support a claim in a maintained document, the version used should be cited. Otherwise the document and the data drift apart silently. It is…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #15 · Outcomes › Progress reports · 4 Mar 2026 · 29 likes Narrowing post #12, because the general version has more than one answer. Seasonal patterns: some people report weight loss is slower in winter than summer. Body…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #8 · Analytics › Impurities & related substances · 20 Feb 2026 · 4 likes Answering the question post #6 raises rather than the one it answers. Peptide impurities that differ by a single residue are the hardest to resolve and the most likely…
-
Coming back to: Training through a dose escalation week Replied, post #29 · Nutrition & Training › Resistance training · 14 Feb 2026 · 0 likes Narrowing post #28, because the general version has more than one answer. The reports here that state the programme, the load and the timeframe are useful. The ones…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #124 · Clinical › Special populations · 27 Jan 2026 · 30 likes Coming back to post #120, because the follow-up matters more than the original answer. If someone has run Pregnancy and pregnancy planning properly I would rather read…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #25 · Clinical › Special populations · 27 Jan 2026 · 0 likes Source for the pregnancy and pregnancy planning figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #14 · Practice › Reconstitution · 22 Jan 2026 · 0 likes I think the Foaming during reconstitution question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Reused chromatograms across lots: how to spot it Replied, post #14 · Analytics › COA interpretation · 16 Jan 2026 · 23 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #48 · Access › International · 10 Jan 2026 · 8 likes Coming back to post #46, because the follow-up matters more than the original answer. Language barriers in accessing came up in a thread eighteen months ago and was…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #16 · Sourcing › Logistics · 2 Jan 2026 · 20 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Documentation that appears only after payment Replied, post #114 · Sourcing › Red flags · 22 Dec 2025 · 0 likes This follows post #113 rather than contradicting it. A stock listing that never changes and a lead time that never varies are both worth noticing. Real operations have…
-
Substitution between formats during a shortage Replied, post #115 · Access › Shortages · 13 Dec 2025 · 18 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
Where impurities in solid-phase peptide synthesis come from Replied, post #23 · Analytics › Impurities & related substances · 28 Nov 2025 · 7 likes Everything in post #21 holds. The case it does not cover is the one I have. Truncation products: fragments from incomplete synthesis or from degradation. They elute…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #46 · Practice › Reconstitution · 24 Nov 2025 · 18 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #38 · Clinical › Special populations · 24 Nov 2025 · 0 likes Counterpoint on older adults, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #7 · Practice › Interactions · 24 Nov 2025 · 30 likes Insulin and sulfonylureas are the interaction that the labelling in this class flags most explicitly, because the risk is additive glucose lowering. That is a…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #94 · Start Here › How to Ask · 14 Nov 2025 · 26 likes Post #93 describes the usual case. This is about the unusual one. Do not apologise in the first line. It costs you the space where the question should be, and nobody…
-
Guidelines revision: what changed and why — one year on Replied, post #35 · Meta › Announcements · 13 Nov 2025 · 25 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #107 · Lounge › Off topic · 19 Oct 2025 · 6 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion. The…
-
Compounds this community declines to help with, and why Replied, post #38 · Compounds › Other compounds · 30 Sep 2025 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
What pooling buys you and what it destroys Replied, post #22 · Evidence › Meta-analyses · 15 Sep 2025 · 15 likes That is clearer than the version I had in my head. Thank you.
-
When a preprint is the best available evidence and we say so Replied, post #154 · Evidence › Preprints · 8 Sep 2025 · 16 likes Post #150 describes the usual case. This is about the unusual one. Author track record is a weak signal and it is a signal. A group that has published carefully for…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #102 · Practice › Reconstitution · 8 Aug 2025 · 9 likes Research-use-only material reconstituted at home is not a compounded sterile preparation and nothing about the procedure makes it one. Members describing what they do…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #34 · Practice › Reconstitution · 21 Jul 2025 · 2 likes Post #30 put the caveat in the right place and I want to underline it. Over-dilution is a good example of a question where the honest answer is boring and the…
-
Coming back to: Why the cheapest option is often not the cheapest Replied, post #26 · Access › Pricing · 3 Jul 2025 · 8 likes I had written a reply contradicting post #24 and deleted it. Here is what survived. If someone has run cheapest option properly I would rather read that than my own…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #75 · Practice › Reconstitution · 24 Jun 2025 · 6 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
When to stop reading forums, including this one Started this topic · Wellbeing › Mental health · 19 Jun 2025 · 47 likes When to stop reading forums, including this one I have a specific reason for asking rather than idle curiosity, and the context is below. Something that has come up for…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #80 · Compounds › Cagrilintide & amylin analogues · 13 Jun 2025 · 11 likes I read post #78 twice before replying, because I had assumed the opposite. The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a…
-
Insulin combinations and hypoglycaemia risk Replied, post #4 · Practice › Interactions · 9 Jun 2025 · 8 likes Worth separating two things that the opening post runs together. If you are new and reading this thread for the answer to insulin combinations and hypoglycaemia risk:…
-
A ten-fold dose error caught before injection Replied, post #46 · Devices › Syringes & needles · 8 Jun 2025 · 3 likes The documentation on ten-fold dose error caught is better than this thread and I say that as someone who has posted in the thread.
-
Lipase elevation without symptoms: the interpretation problem — a second dataset Replied, post #8 · Clinical › Bloodwork · 2 Jun 2025 · 14 likes Everything in post #6 holds. The case it does not cover is the one I have. On Lipase elevation without symptoms, I would rather understate and be corrected upward than…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #2 · Nutrition & Training › Protein & intake · 1 Jun 2025 · 0 likes Following this. I have the same question and no better information than the first post.
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #23 · Evidence › Journal club · 27 May 2025 · 5 likes Helpful, and easy to find again, which is half of what a good reply is.
-
A report I filed that turned out to be wrong, and the correction Replied, post #39 · Sourcing › Vendor reports · 4 May 2025 · 0 likes This follows post #36 rather than contradicting it. The maintainers will ask for missing fields rather than rejecting a report. Filling them in afterwards is normal and…
-
Units, standards, and other things that quietly hold the world together Replied, post #24 · Lounge › Off topic · 20 Apr 2025 · 0 likes Posting my units numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular answer.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #40 · Evidence › Journal club · 19 Apr 2025 · 22 likes Post #37 is right about the mechanism and I think understates the practical bit. Second-hand on STEP 1, so weight it accordingly — someone whose method I trust told me…
-
Certificates issued by the seller versus by a laboratory Replied, post #33 · Analytics › COA interpretation · 6 Apr 2025 · 15 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #5 · Practice › Storage & stability · 13 Mar 2025 · 26 likes An observation about published stability data actually covers that I cannot explain and am posting anyway, on the principle that unexplained observations are more…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #59 · Evidence › Meta-analyses · 5 Feb 2025 · 8 likes Where I part company with post #55, and it is a narrow parting. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #13 · Outcomes › Progress reports · 2 Feb 2025 · 8 likes 18-month record looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Escalating every six weeks instead of four: what I observed over eight months Replied, post #24 · Practice › Dosing & titration · 18 Jan 2025 · 0 likes Trying to state the escalating every six weeks instead position in a way that someone who disagrees would recognise as fair, because I do not think the version in this…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #6 · Wellbeing › Mental health · 16 Jan 2025 · 24 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
Recovery when intake is low: what to cut first Replied, post #28 · Nutrition & Training › Resistance training · 11 Jan 2025 · 6 likes Recovery is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is…
-
Body image changing more slowly than the body Replied, post #101 · Wellbeing › Mental health · 22 Dec 2024 · 23 likes Taking post #98 at face value and following it one step further. My understanding of body image is a few years old and may have been superseded. If it has been, I would…
-
UK access routes, dated and sourced — a second dataset Replied, post #18 · Regional › UK & Ireland · 21 Dec 2024 · 30 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.…
-
Fixed versus detachable needles: the trade-offs Replied, post #48 · Devices › Syringes & needles · 13 Dec 2024 · 0 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #26 · Wellbeing › Mental health · 12 Dec 2024 · 28 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #18 · Devices › Cold chain · 6 Dec 2024 · 0 likes Having read the whole Domestic fridge temperature mapping thread before replying: the question in the first post has not actually been answered yet, and three of us…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #113 · Compounds › Repair & healing peptides · 21 Nov 2024 · 5 likes Confirming post #110 from a second method, which matters more than confirming it from a second person. The absence of adequately powered published randomised human…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #40 · Compounds › Tirzepatide · 23 Oct 2024 · 0 likes Post #36 put the caveat in the right place and I want to underline it. The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging efficacy at that…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #126 · Access › Shortages · 13 Oct 2024 · 4 likes Shortage-driven price movement is real and is a separate question from availability. I have left out the parts I could not verify.
-
Follow-up: Trifluoroacetate content and its consequences Replied, post #6 · Analytics › Impurities & related substances · 13 Oct 2024 · 4 likes Summarising the Trifluoroacetate content thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it,…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #59 · Access › Shortages · 11 Oct 2024 · 6 likes Stockpiling in response to a shortage worsens it, which is true and is a poor argument to make to somebody who has run out.
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #28 · Compounds › Retatrutide · 10 Sep 2024 · 0 likes Nothing to add, except that this is the answer I would give if asked.
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #3 · Compounds › Oral incretins · 25 Aug 2024 · 0 likes Agreed on all of that, and I have nothing to add to it.
-
Circumference measurements as a poor man's composition estimate Replied, post #91 · Outcomes › Body composition · 23 Aug 2024 · 1 like Answering the question post #89 raises rather than the one it answers. Circumference measurements at marked sites, taken consistently, track composition change better…
-
Circumference measurements as a poor man's composition estimate Replied, post #74 · Outcomes › Body composition · 17 Aug 2024 · 6 likes What I would check first on circumference measurements is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a…
-
Assessing a warm arrival: the decision process — one year on Replied, post #14 · Sourcing › Logistics · 28 May 2024 · 0 likes Coming back to post #12, because the follow-up matters more than the original answer. Cold packs and temperature control: inclusion of cold packs at despatch is…